efavirenz, emtricitabine and tenofovir disoproxil fumarate

Cipla USA Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 11, 2021
Approval ID: a7d94a1c-31b0-4272-8f8d-186d580e16e0
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral useInitial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.